Quoin Pharmaceuticals (QNRX) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quoin Pharmaceuticals (QNRX) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, losing 44.4% versus a loss of 87.4%. Shuttle Pharmaceuticals is the larger company by market cap ($25.4 million vs $21.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QNRX | SHPH |
|---|---|---|
| Share price | $4.50 | $5.33 |
| Market cap | $21.62M | $25.40M |
| 1-day change | -1.10% | -4.05% |
| YTD return | -68.47% | -69.17% |
| 1-year return | -44.44% | -87.36% |
| 5-year return | -99.99% | — |
| EPS (TTM) | $-5.67 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $41.80 | $55.90 |
| 52-week low | $3.25 | $2.58 |
| Distance from 52-week high | -89.23% | -90.47% |
| Analyst consensus | none | — |
| Avg. price target upside | +385.11% | — |
| Average volume | 541.11K | 1.36M |
| Shares outstanding | 4.80M | 4.76M |
| Employees | 4 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QNRX has outperformed SHPH by 42.9 percentage points over the past year.
About Quoin Pharmaceuticals
QNRX stock →Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Shuttle Pharmaceuticals
SHPH stock →Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
QNRX vs SHPH FAQ
Which is bigger, Quoin Pharmaceuticals or Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals (SHPH) is larger, with a market capitalization of $25.40M compared with $21.62M for Quoin Pharmaceuticals (QNRX).
Which stock has performed better over the past year, QNRX or SHPH?
QNRX returned -44.44% over the past 12 months, compared with -87.36% for SHPH (price return, excluding dividends). Past performance does not predict future results.
Are Quoin Pharmaceuticals and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.